PR Hub

Inclinix Inc.

Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers' Diarrhea Vaccine Study


WILMINGTON, North Carolina, June 3, 2010 - Intercell AG has retained Inclinix, Inc., to recruit volunteers for their Phase III clinical trial of an investigational Travelers' Diarrhea (TD) vaccine system.
MORE..
Older News
S M T W T F S
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times